TOTAL-BODY AND MYOCARDIAL SUBSTRATE OXIDATION IN CONGESTIVE-HEART-FAILURE
TOTAL-BODY AND MYOCARDIAL SUBSTRATE OXIDATION IN CONGESTIVE-HEART-FAILURE
复制标题
DOI:
10.1016/0026-0495(94)90241-0
复制
发表时间:
1994-02-01
影响因子:
9.8
通讯作者:
DONOFRIO, F
中科院分区:
文献类型:
--
作者:
PAOLISSO, G;GAMBARDELLA, A;DONOFRIO, F
Congestive heart failure is a condition associated with increased plasma norepinephrine levels, which have been demonstrated to impair glucose handling. In the present study, 10 patients suffering from congestive heart failure and 10 healthy age- and body mass index-matched subjects were submitted to a hyperinsulinemic (insulin infusion rate, 0.5 mU/kg · min−1) glucose clamp, while simultaneousd-3H-glucose infusion and indirect calorimetry allowed for determination of glucose turnover parameters and substrate oxidation, respectively. On a separate day, basal local (myocardial) indirect calorimetry was also performed. Our data demonstrate that in congestive heart failure, fasting myocardial glucose oxidation (Gox) was inhibited with a simultaneous increase in lipid oxidation (Lox). In our patients, a significant decrease in total-body insulin-stimulated glucose metabolism (31.0 ± 0.5v20.3 ± 0.4 μmol/kg · min−1,P< .01) and nonoxidative glucose metabolism (18.9 ± 1.1v11.0 ± 0.5 μmol/kg · min−1,P< .05) was also found. Such latter changes were also associated with a simultaneous overdrive of Lox (0.4 ± 0.2v1.9 ± 0.2 μmol/kg · min−1,P< .02) that was correlated with an enhanced availability of plasma free fatty acids (FFAs).